Kindred Biosciences, Inc.
Variant Asparaginase Polypeptides for Medical Use

Last updated:

Abstract:

Provided are various embodiments relating to variant asparaginase polypeptides with enhanced stability, pharmacodynamics, and/or reduced immunogenicity. The variant asparaginase polypeptides may be used as therapeutics in mammals, including human, canines, felines, and equines.

Status:
Application
Type:

Utility

Filling date:

18 Apr 2019

Issue date:

4 Mar 2021